Encoded Therapeutics Inc., a clinical-stage genetic medicines company, today announced its participation in the 29th Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT), taking place ...
Oral presentation highlights novel compact RT editor demonstrating first preclinical in vivo proof of concept for precise ...
Intellia Therapeutics said its Crispr-based treatment for hereditary angioedema met its goals in a Phase 3 trial, marking a ...
The authors provide valuable findings showing that GM-CSF prevents the loss of ILC3 populations during gut inflammation and inhibits pro-inflammatory cytokine production. They combine a preclinical ...
A new therapy has the potential to cure hundreds of diseases — and even reverse aging. Credit...Photo illustration by Kensuke ...
SAN FRANCISCO, April 27, 2026 (GLOBE NEWSWIRE) -- Siren Biotechnology today announced the publication of its first peer-reviewed manuscript in Molecular Therapy Oncology, alongside upcoming ...
China Medical System Holdings Limited ("CMS" or the "Group") is pleased to announce that, the Group through its wholly-owned subsidiary entered into ...
Phase 2 studies ongoing to advance global development of vebreltinib, a highly potent, de-risked and differentiated c-MET Inhibitor with ...
AstraZeneca’s SAPHNELO ® (anifrolumab-fnia) has been approved in the US for self-administration as a once-weekly autoinjector ...
It started with basic insights from pregnancy but an MUSC researcher is seeking to manipulate immune cells to protect insulin ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results